{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:44:24Z","timestamp":1792118664484,"version":"4.4.0"},"reference-count":278,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T00:00:00Z","timestamp":1627689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST-106-2320-B-038-049-MY3"],"award-info":[{"award-number":["MOST-106-2320-B-038-049-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST-108-2314-B-038-022"],"award-info":[{"award-number":["MOST-108-2314-B-038-022"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>The blood\u2013brain barrier (BBB) plays a vital role in the protection and maintenance of homeostasis in the brain. In this way, it is an interesting target as an interface for various types of drug delivery, specifically in the context of the treatment of several neuropathological conditions where the therapeutic agents cannot cross the BBB. Drug toxicity and on-target specificity are among some of the limitations associated with current neurotherapeutics. In recent years, advances in nanodrug delivery have enabled the carrier system containing the active therapeutic drug to target the signaling pathways and pathophysiology that are closely linked to central nervous system (CNS) disorders such as Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD), Huntington\u2019s disease (HD), multiple sclerosis (MS), brain tumor, epilepsy, ischemic stroke, and neurodegeneration. At present, among the nano formulations, solid lipid nanoparticles (SLNs) have emerged as a putative drug carrier system that can deliver the active therapeutics (drug-loaded SLNs) across the BBB at the target site of the brain, offering a novel approach with controlled drug delivery, longer circulation time, target specificity, and higher efficacy, and more importantly, reducing toxicity in a biomimetic way. This paper highlights the synthesis and application of SLNs as a novel nontoxic formulation strategy to carry CNS drugs across the BBB to improve the use of therapeutics agents in treating major neurological disorders in future clinics.<\/jats:p>","DOI":"10.3390\/pharmaceutics13081183","type":"journal-article","created":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T21:44:32Z","timestamp":1627854272000},"page":"1183","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":299,"title":["Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6646-7928","authenticated-orcid":false,"given":"Mantosh Kumar","family":"Satapathy","sequence":"first","affiliation":[{"name":"Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, No. 250, Wu Hsing St., Taipei 110, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1454-0521","authenticated-orcid":false,"given":"Ting-Lin","family":"Yen","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, No. 250, Wu Hsing St., Taipei 110, Taiwan"},{"name":"Department of Medical Research, Cathay General Hospital, Taipei 22174, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Shiun","family":"Jan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, No. 250, Wu Hsing St., Taipei 110, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruei-Dun","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, No. 250, Wu Hsing St., Taipei 110, Taiwan"},{"name":"Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, No. 250, Wu Hsing St., Taipei 110, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9106-3351","authenticated-orcid":false,"given":"Jia-Yi","family":"Wang","sequence":"additional","affiliation":[{"name":"Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, No. 250, Wu Hsing St., Taipei 110, Taiwan"},{"name":"Department of Neurosurgery, Taipei Medical University Hospital, Taipei 110, Taiwan"},{"name":"Neuroscience Research Center, Taipei Medical University, Taipei 110, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2147-2990","authenticated-orcid":false,"given":"Rajeev","family":"Taliyan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Neuropsychopharmacology Division, Birla Institute of Technology and Science, Pilani 333031, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8354-7874","authenticated-orcid":false,"given":"Chih-Hao","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, No. 250, Wu Hsing St., Taipei 110, Taiwan"},{"name":"Neuroscience Research Center, Taipei Medical University, Taipei 110, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.3390\/ijms10062510","article-title":"Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders","volume":"10","author":"Choonara","year":"2009","journal-title":"Int. J. Mol. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.archger.2011.03.002","article-title":"Parkinson\u2019s disease (PD) in the elderly: An example of geriatric syndrome (GS)?","volume":"54","author":"Lauretani","year":"2012","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2010.09.016","article-title":"Brain molecular aging, promotion of neurological disease and modulation by Sirtuin5 longevity gene polymorphism","volume":"41","author":"Glorioso","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pneurobio.2010.11.006","article-title":"Between destiny and disease: Genetics and molecular pathways of human central nervous system aging","volume":"93","author":"Glorioso","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1517\/17425247.2013.784742","article-title":"Advances in brain drug targeting and delivery: Limitations and challenges of solid lipid nanoparticles","volume":"10","author":"Patel","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1517\/17425240902758188","article-title":"Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases","volume":"6","author":"Barchet","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_7","first-page":"498","article-title":"Albumin microspheres for study of the reticuloendothelial system","volume":"13","author":"Scheffel","year":"1972","journal-title":"J. Nucl. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2174\/187221108784534081","article-title":"Recent advances and patents on solid lipid nanoparticles","volume":"2","author":"Sawant","year":"2008","journal-title":"Recent Pat. Drug Deliv. Formul."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pharmthera.2004.08.001","article-title":"Delivery of therapeutic agents to the central nervous system: The problems and the possibilities","volume":"104","author":"Begley","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrd2368","article-title":"Modelling of the blood\u2013brain barrier in drug discovery and development","volume":"6","author":"Cecchelli","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/PPO.0b013e318244d8ae","article-title":"Novel delivery strategies for glioblastoma","volume":"18","author":"Zhou","year":"2012","journal-title":"Cancer J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1586\/14737175.6.10.1495","article-title":"Advances in strategies to improve drug delivery to brain tumors","volume":"6","author":"Newton","year":"2006","journal-title":"Expert Rev. Neurother."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.neuron.2012.08.019","article-title":"Synaptic energy use and supply","volume":"75","author":"Harris","year":"2012","journal-title":"Neuron"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/HYP.0000000000000053","article-title":"Impact of hypertension on cognitive function: A scientific statement from the American Heart Association","volume":"68","author":"Iadecola","year":"2016","journal-title":"Hypertension"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The blood-brain barrier in health and chronic neurodegenerative disorders","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood\u2013brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1469-7580.2002.00047_13.x","article-title":"Astrocyte\u2013endothelial interactions and blood\u2013brain barrier permeability","volume":"200","author":"Abbott","year":"2002","journal-title":"J. Anat."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1385\/MB:30:1:057","article-title":"Molecular biology of the blood-brain barrier","volume":"30","author":"Pardridge","year":"2005","journal-title":"Mol. Biotechnol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1021\/jm00180a022","article-title":"Relationship of octanol\/water partition coefficient and molecular weight to rat brain capillary permeability","volume":"23","author":"Levin","year":"1980","journal-title":"J. Med. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1021\/jm000407e","article-title":"Property-based design: Optimization of drug absorption and pharmacokinetics","volume":"44","author":"Smith","year":"2001","journal-title":"J. Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/0023210-200923010-00003","article-title":"Getting into the brain","volume":"23","author":"Patel","year":"2009","journal-title":"CNS Drugs"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4155\/tde.14.114","article-title":"Delivery of local therapeutics to the brain: Working toward advancing treatment for malignant gliomas","volume":"6","author":"Chaichana","year":"2015","journal-title":"Ther. Deliv."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.brainresbull.2018.10.009","article-title":"Evaluation of intranasal delivery route of drug administration for brain targeting","volume":"143","author":"Bors","year":"2018","journal-title":"Brain Res. Bull."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jconrel.2018.05.011","article-title":"Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs","volume":"281","author":"Agrawal","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jconrel.2017.11.047","article-title":"Nanosystems in nose-to-brain drug delivery: A review of non-clinical brain targeting studies","volume":"270","author":"Pires","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijpharm.2009.06.019","article-title":"Nanoparticles for direct nose-to-brain delivery of drugs","volume":"379","author":"Mistry","year":"2009","journal-title":"Int. J. Pharm."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ejpb.2018.05.009","article-title":"Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics","volume":"128","author":"Bourganis","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"G\u00e4nger, S., and Schindowski, K. (2018). Tailoring formulations for intranasal nose-to-brain delivery: A review on architecture, physico-chemical characteristics and mucociliary clearance of the nasal olfactory mucosa. Pharmaceutics, 10.","DOI":"10.3390\/pharmaceutics10030116"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","article-title":"Intranasal delivery of biologics to the central nervous system","volume":"64","author":"Lochhead","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2217\/nnm.16.15","article-title":"Nanoparticles for brain-specific drug and genetic material delivery, imaging and diagnosis","volume":"11","author":"Posadas","year":"2016","journal-title":"Nanomedicine"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Blanchette, M., and Fortin, D. (2011). Blood-brain barrier disruption in the treatment of brain tumors. The Blood-Brain and Other Neural Barriers, Springer.","DOI":"10.1007\/978-1-60761-938-3_23"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.nano.2012.02.003","article-title":"Enhanced delivery of gold nanoparticles with therapeutic potential into the brain using MRI-guided focused ultrasound","volume":"8","author":"Etame","year":"2012","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.ultrasmedbio.2009.03.012","article-title":"Blood-brain barrier (BBB) disruption using a diagnostic ultrasound scanner and Definity\u00ae in mice","volume":"35","author":"Bing","year":"2009","journal-title":"Ultrasound Med. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jconrel.2017.08.033","article-title":"Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases","volume":"264","author":"Tapeinos","year":"2017","journal-title":"J. Control. Release"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"119326","DOI":"10.1016\/j.lfs.2021.119326","article-title":"Targeting receptor-ligand chemistry for drug delivery across blood-brain barrier in brain diseases","volume":"274","author":"Anthony","year":"2021","journal-title":"Life Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1602\/neurorx.2.4.554","article-title":"Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery","volume":"2","author":"Alavijeh","year":"2005","journal-title":"NeuroRx"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Rakotoarisoa, M., and Angelova, A. (2018). Amphiphilic nanocarrier systems for curcumin delivery in neurodegenerative disorders. Medicines, 5.","DOI":"10.3390\/medicines5040126"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0928-0987(99)00071-8","article-title":"Lipid emulsions as a novel system to reduce the hemolytic activity of lytic agents: Mechanism of the protective effect","volume":"9","author":"Jumaa","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jconrel.2007.12.018","article-title":"Potential of solid lipid nanoparticles in brain targeting","volume":"127","author":"Kaur","year":"2008","journal-title":"J. Control. Release"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1248\/cpb.49.1444","article-title":"In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel","volume":"49","author":"Chen","year":"2001","journal-title":"Chem. Pharm. Bull."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2478\/v10007-012-0040-z","article-title":"Solid lipid based nanocarriers: An overview","volume":"62","author":"Pardeshi","year":"2012","journal-title":"Acta Pharm."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery\u2014A review of the state of the art","volume":"50","author":"Gohla","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0378-5173(98)00092-1","article-title":"Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN\u2122) dispersions","volume":"168","author":"Freitas","year":"1998","journal-title":"Int. J. Pharm."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4103\/0250-474X.57282","article-title":"Solid lipid nanoparticles: A modern formulation approach in drug delivery system","volume":"71","author":"Mukherjee","year":"2009","journal-title":"Indian J. Pharm. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jconrel.2004.02.029","article-title":"Transfection with different colloidal systems: Comparison of solid lipid nanoparticles and liposomes","volume":"97","author":"Tabatt","year":"2004","journal-title":"J. Control. Release"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-5173(03)00229-1","article-title":"Physical and thermal characterisation of Precirol\u00ae and Compritol\u00ae as lipophilic glycerides used for the preparation of controlled-release matrix pellets","volume":"260","author":"Hamdani","year":"2003","journal-title":"Int. J. Pharm."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/jps.23522","article-title":"Docetaxel-loaded solid lipid nanoparticles: Preparation, characterization, in vitro, and in vivo evaluations","volume":"102","author":"Mosallaei","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0168-3659(99)00007-3","article-title":"Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain","volume":"59","author":"Yang","year":"1999","journal-title":"J. Control. Release"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jconrel.2005.06.006","article-title":"Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration","volume":"107","author":"Manjunath","year":"2005","journal-title":"J. Control. Release"},{"key":"ref_51","first-page":"61","article-title":"Scaling up feasibility of the production of solid lipid nanoparticles (SLN)","volume":"56","author":"Gohla","year":"2001","journal-title":"Die Pharm."},{"key":"ref_52","first-page":"80","article-title":"Solid lipid nanoparticles: A review","volume":"2","author":"Sathali","year":"2012","journal-title":"Sci. Revs. Chem. Commun"},{"key":"ref_53","first-page":"313","article-title":"A modern review on solid lipid nanoparticles as novel controlled drug delivery system","volume":"3","author":"Reddy","year":"2014","journal-title":"Int. J. Res. Pharm. Nano Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3329\/icpj.v1i11.12065","article-title":"Solid lipid nanoparticles (SLN): Method, characterization and applications","volume":"1","author":"Garud","year":"2012","journal-title":"Int. Curr. Pharm. J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/026520499289185","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery II. Drug incorporation and physicochemical characterization","volume":"16","author":"Schwarz","year":"1999","journal-title":"J. Microencapsul."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0939-6411(98)00074-5","article-title":"Correlation between long-term stability of solid lipid nanoparticles (SLN\u2122) and crystallinity of the lipid phase","volume":"47","author":"Freitas","year":"1999","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/phrs.2000.0695","article-title":"Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: Pharmacokinetics and tissue distribution after iv administration to rats","volume":"42","author":"Cavalli","year":"2000","journal-title":"Pharmacol. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1358\/dof.2004.029.01.872585","article-title":"Novel delivery systems for drug targeting to the brain","volume":"29","author":"Reddy","year":"2004","journal-title":"Drugs Future"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejpb.2017.04.013","article-title":"Surface modification of solid lipid nanoparticles for oral delivery of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake","volume":"117","author":"Baek","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jconrel.2003.08.006","article-title":"Brain uptake of thiamine-coated nanoparticles","volume":"93","author":"Lockman","year":"2003","journal-title":"J. Control. Release"},{"key":"ref_61","unstructured":"Dingler, A. (1998). Feste Lipid-Nanopartikel als Kolloidale Wirkstofftr\u00e4gersysteme zur Dermalen Applikation. [Ph.D. Thesis, Freie Universit\u00e4t Berlin]."},{"key":"ref_62","first-page":"62","article-title":"Solid lipid nanoparticles (SLN): An alternative colloidal carrier system for controlled drug delivery","volume":"41","author":"Mehnert","year":"1995","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0939-6411(97)00150-1","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery\u2013drug release and release mechanism","volume":"45","author":"Schwarz","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.colsurfb.2013.06.032","article-title":"Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability","volume":"111","author":"Sun","year":"2013","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.colsurfb.2012.08.058","article-title":"Solid lipid nanoparticles as delivery systems for Gambogenic acid","volume":"102","author":"Huang","year":"2013","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s12010-014-1084-y","article-title":"Chitosan-assisted immunotherapy for intervention of experimental leishmaniasis via amphotericin B-loaded solid lipid nanoparticles","volume":"174","author":"Jain","year":"2014","journal-title":"Appl. Biochem. Biotechnol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1002\/jps.22435","article-title":"Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: In vitro and in vivo evaluation","volume":"100","author":"Rawat","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0168-3659(97)00046-1","article-title":"Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential","volume":"48","author":"Westesen","year":"1997","journal-title":"J. Control. Release"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0378-5173(93)90177-H","article-title":"Investigations on the physical state of lipid nanoparticles by synchrotron radiation X-ray diffraction","volume":"93","author":"Westesen","year":"1993","journal-title":"Int. J. Pharm."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijpharm.2005.03.022","article-title":"Development and application of high throughput plasma stability assay for drug discovery","volume":"297","author":"Di","year":"2005","journal-title":"Int. J. Pharm."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4161\/cbt.7.3.5363","article-title":"Differential response of human glioblastoma cell lines to combined camptothecin and ionizing radiation treatment","volume":"7","author":"Djuzenova","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/sj.bjp.0704363","article-title":"Effect of P-glycoprotein modulators on the pharmacokinetics of camptothecin using microdialysis","volume":"134","author":"Tsai","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1023\/A:1018888927852","article-title":"Body distribution of camptothecin solid lipid nanoparticles after oral administration","volume":"16","author":"Yang","year":"1999","journal-title":"Pharm. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ejpb.2013.08.011","article-title":"Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration","volume":"85","author":"Martins","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijpharm.2012.09.054","article-title":"Brain delivery of camptothecin by means of solid lipid nanoparticles: Formulation design, in vitro and in vivo studies","volume":"439","author":"Martins","year":"2012","journal-title":"Int. J. Pharm."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1080\/10611860600888850","article-title":"Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration","volume":"14","author":"Manjunath","year":"2006","journal-title":"J. Drug Target."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0939-6411(02)00083-8","article-title":"Enhanced brain targeting by synthesis of 3\u02b9, 5\u02b9 -dioctanoyl-5-fluoro-2\u02b9 -deoxyuridine and incorporation into solid lipid nanoparticles","volume":"54","author":"Wang","year":"2002","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.nano.2012.10.003","article-title":"Poly (ethylene)-glycol conjugated solid lipid nanoparticles of noscapine improve biological half-life, brain delivery and efficacy in glioblastoma cells","volume":"9","author":"Madan","year":"2013","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1006\/phrs.1999.0509","article-title":"Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN)","volume":"40","author":"Zara","year":"1999","journal-title":"Pharmacol. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2217\/nnm.09.67","article-title":"Brain-targeted solid lipid nanoparticles containing riluzole: Preparation, characterization and biodistribution","volume":"5","author":"Craparo","year":"2010","journal-title":"Nanomedicine"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jconrel.2004.07.006","article-title":"Paclitaxel nanoparticles for the potential treatment of brain tumors","volume":"99","author":"Koziara","year":"2004","journal-title":"J. Control. Release"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrn1824","article-title":"Astrocyte-endothelial interactions at the blood-brain barrier","volume":"7","author":"Abbott","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.2174\/13816128113199990463","article-title":"Transporters at CNS barrier sites: Obstacles or opportunities for drug delivery?","volume":"20","author":"Slosky","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2003.12.016","article-title":"The blood\u2013brain barrier: An overview: Structure, regulation, and clinical implications","volume":"16","author":"Ballabh","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pharmthera.2012.07.006","article-title":"Insulin in the brain: There and back again","volume":"136","author":"Banks","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"12079","DOI":"10.1073\/pnas.96.21.12079","article-title":"Selective expression of the large neutral amino acid transporter at the blood\u2013brain barrier","volume":"96","author":"Boado","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Zhang, Z., and Zhan, C. (2019). Receptor-mediated transportation through BBB. Brain Targeted Drug Delivery System, Elsevier.","DOI":"10.1016\/B978-0-12-814001-7.00005-6"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00018-018-2982-x","article-title":"Intracellular transport and regulation of transcytosis across the blood\u2013brain barrier","volume":"76","author":"Lampe","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3389\/fnins.2018.01019","article-title":"Transcytosis to cross the blood brain barrier, new advancements and challenges","volume":"12","author":"Pulgar","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s11095-007-9379-0","article-title":"Blood\u2013brain barrier transport of therapeutics via receptor-mediation","volume":"24","author":"Jones","year":"2007","journal-title":"Pharm. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/bs.apha.2014.06.001","article-title":"Transcytosis of macromolecules at the blood\u2013brain barrier","volume":"71","author":"Preston","year":"1995","journal-title":"Adv. Pharmacol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1208\/s12248-008-9055-2","article-title":"CNS delivery via adsorptive transcytosis","volume":"10","author":"Ghinea","year":"2008","journal-title":"AAPS J."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.2174\/138920112803341851","article-title":"Adsorptive-mediated brain delivery systems","volume":"13","author":"Lu","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Zhu, X., Jin, K., Huang, Y., and Pang, Z. (2019). Brain drug delivery by adsorption-mediated transcytosis. Brain Targeted Drug Delivery System, Elsevier.","DOI":"10.1016\/B978-0-12-814001-7.00007-X"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0169-409X(93)90048-9","article-title":"Pardridge, Delivery of peptides and proteins through the blood-brain barrier","volume":"10","author":"Bickel","year":"1993","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0928-0987(00)00081-6","article-title":"Preparation and characterization of solid lipid nanospheres containing paclitaxel","volume":"10","author":"Cavalli","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1182\/blood.V41.4.529.529","article-title":"The role of the sinus wall in the passage of erythrocytes through the spleen","volume":"41","author":"Chen","year":"1973","journal-title":"Blood"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0006-291X(91)91869-E","article-title":"Non-phagocytic uptake of intravenously injected microspheres in rat spleen: Influence of particle size and hydrophilic coating","volume":"177","author":"Moghimi","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_100","unstructured":"Jain, N. (2008). Advances in Controlled and Novel Drug Delivery, CBS Publishers & Distributors."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1602\/neurorx.2.1.108","article-title":"Drug transport to brain with targeted nanoparticles","volume":"2","author":"Olivier","year":"2005","journal-title":"NeuroRx"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jconrel.2004.01.002","article-title":"Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice","volume":"95","author":"Oyewumi","year":"2004","journal-title":"J. Control. Release"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0169-409X(00)00122-8","article-title":"Nanoparticulate systems for brain delivery of drugs","volume":"47","author":"Kreuter","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1023\/A:1012098005098","article-title":"Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles","volume":"14","author":"Alyautdin","year":"1997","journal-title":"Pharm. Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/10611860290031868","article-title":"Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: Pharmacokinetics and distribution of doxorubicin in brain and other tissues","volume":"10","author":"Zara","year":"2002","journal-title":"J. Drug Target."},{"key":"ref_106","unstructured":"Carmona-Ribeiro, A.M., Barbassa, L., and De Melo, L.D. (2011). Antimicrobial biomimetics. Biomimetic Based Applications, IntechOpen."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1006\/phrs.2001.0813","article-title":"Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II\u2014Tissue distribution","volume":"43","author":"Bargoni","year":"2001","journal-title":"Pharmacol. Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrd725","article-title":"Drug and gene targeting to the brain with molecular Trojan horses","volume":"1","author":"Pardridge","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/156720106776359230","article-title":"A review of nanocarrier-based CNS delivery systems","volume":"3","author":"Tiwari","year":"2006","journal-title":"Curr. Drug Deliv."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/10611860290031840","article-title":"Uptake of cationized albumin coupled liposomes by cultured porcine brain microvessel endothelial cells and intact brain capillaries","volume":"10","author":"Nobmann","year":"2002","journal-title":"J. Drug Target"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"109006","DOI":"10.1016\/j.biopha.2019.109006","article-title":"Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo","volume":"116","author":"Zheng","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejpb.2018.09.012","article-title":"Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy","volume":"132","author":"Kadari","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/21691401.2017.1313267","article-title":"RAGE receptor targeted bioconjuguate lipid nanoparticles of diallyl disulfide for improved apoptotic activity in triple negative breast cancer: In vitro studies","volume":"46","author":"Siddhartha","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ijbiomac.2020.02.132","article-title":"Oral delivery of pH-responsive alginate microbeads incorporating folic acid-grafted solid lipid nanoparticles exhibits enhanced targeting effect against colorectal cancer: A dual-targeted approach","volume":"151","author":"Rajpoot","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"115682","DOI":"10.1016\/j.carbpol.2019.115682","article-title":"Targeted delivery and apoptosis induction of trans-resveratrol-ferulic acid loaded chitosan coated folic acid conjugate solid lipid nanoparticles in colon cancer cells","volume":"231","author":"Kumar","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"M\u00fcller, R., Schwarz, C., Zur M\u00fchlen, A., and Mehnert, W. (1994, January 27\u201330). Incorporation of lipophilic drugs and drug release profiles of solid lipid nanoparticles (SLN). Proceedings of International Symposium on Controlled Release of Bioactive Materials, Nice, France.","DOI":"10.1016\/0168-3659(94)90047-7"},{"key":"ref_117","first-page":"552","article-title":"Drug release and release mechanism of prednisolone loaded solid lipid nanoparticles","volume":"53","author":"Mehnert","year":"1998","journal-title":"Pharmazie"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0168-3659(94)90047-7","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization","volume":"30","author":"Schwarz","year":"1994","journal-title":"J. Control. Release"},{"key":"ref_119","first-page":"51","article-title":"Techniques for the preparation of solid lipid nano and microparticles","volume":"1","author":"Battaglia","year":"2014","journal-title":"Appl. Nanotechnol. Drug Deliv."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2012.09.021","article-title":"Solid lipid nanoparticles: Production, characterization and applications","volume":"64","author":"Mehnert","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Mishra, V., Bansal, K.K., Verma, A., Yadav, N., Thakur, S., Sudhakar, K., and Rosenholm, J.M. (2018). Solid lipid nanoparticles: Emerging colloidal nano drug delivery systems. Pharmaceutics, 10.","DOI":"10.3390\/pharmaceutics10040191"},{"key":"ref_122","unstructured":"Battaglia, L., Trotta, M., and Cavalli, R. (2008). Method for the Preparation of Solid Micro and Nanoparticles. (WO2008149215), WIPO Patent."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3109\/02652040903031279","article-title":"Solid lipid nanoparticles produced through a coacervation method","volume":"27","author":"Battaglia","year":"2010","journal-title":"J. Microencapsul."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1773-2247(10)50028-5","article-title":"Amphotericin B loaded SLN prepared with the coacervation technique","volume":"20","author":"Bianco","year":"2010","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3109\/02652048.2011.590615","article-title":"Formulation of curcumin-loaded solid lipid nanoparticles produced by fatty acids coacervation technique","volume":"28","author":"Chirio","year":"2011","journal-title":"J. Microencapsul."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0168-3659(03)00120-2","article-title":"Lipid microparticles as sustained release system for a GnRH antagonist (Antide)","volume":"89","author":"Chicco","year":"2003","journal-title":"J. Control. Release"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3109\/03639040903241817","article-title":"Electrospray technique for solid lipid-based particle production","volume":"36","author":"Trotta","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1080\/01932691.2010.505876","article-title":"Preparation and characterization of insulin-loaded lipid-based microspheres generated by electrospray","volume":"32","author":"Bussano","year":"2011","journal-title":"J. Dispers. Sci. Technol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.addr.2007.09.001","article-title":"Nanoparticles synthesis using supercritical fluid technology\u2013towards biomedical applications","volume":"60","author":"Byrappa","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.addr.2007.04.012","article-title":"Nanostructured lipid carriers (NLC) in cosmetic dermal products","volume":"59","author":"Petersen","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_131","unstructured":"M\u00fcller, R.H., Jenning, V., Mader, K., and Lippacher, A. (2014). Lipid Particles on the Basis of Mixtures of Liquid and Solid Lipids and Method for Producing Same. (US 8663692), US Patent."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/02652040010018056","article-title":"Production of solid lipid nanoparticles (SLN): Scaling up feasibilities","volume":"19","author":"Dingler","year":"2002","journal-title":"J. Microencapsul."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.cej.2008.07.024","article-title":"Preparation of solid lipid nanoparticles in co-flowing microchannels","volume":"144","author":"Zhang","year":"2008","journal-title":"Chem. Eng. J."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/02652049209021226","article-title":"Process and formulation variables in the preparation of wax microparticles by a melt dispersion technique. I. Oil-in-water technique for water-insoluble drugs","volume":"9","author":"Bodmeier","year":"1992","journal-title":"J. Microencapsul."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/02652049209021227","article-title":"Process and formulation variables in the preparation of wax microparticles by a melt dispersion technique. II. W\/O\/W multiple emulsion technique for water-soluble drugs","volume":"9","author":"Bodmeier","year":"1992","journal-title":"J. Microencapsul."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jconrel.2005.07.023","article-title":"Preparation of solid lipid nanoparticles using a membrane contactor","volume":"108","author":"Charcosset","year":"2005","journal-title":"J. Control. Release"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/10837450600561182","article-title":"Influence of the formulation for solid lipid nanoparticles prepared with a membrane contactor","volume":"11","author":"Charcosset","year":"2006","journal-title":"Pharm. Dev. Technol."},{"key":"ref_138","unstructured":"Mumper, R.J., and Jay, M. (2006). Microemulsions as Precursors to Solid Nanoparticles. (US 7153525), US Patent."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1007\/s11095-005-7547-7","article-title":"Blood compatibility of cetyl alcohol\/polysorbate-based nanoparticles","volume":"22","author":"Koziara","year":"2005","journal-title":"Pharm. Res."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0378-5173(02)00587-2","article-title":"Influence of formulation parameters on gadolinium entrapment and tumor cell uptake using folate-coated nanoparticles","volume":"251","author":"Oyewumi","year":"2003","journal-title":"Int. J. Pharm."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/152102a0","article-title":"Transparent water-in-oil dispersions: The oleopathic hydro-micelle","volume":"152","author":"Hoar","year":"1943","journal-title":"Nature"},{"key":"ref_142","first-page":"31","article-title":"Colloidal Drug Delivery Systems","volume":"66","author":"Attwood","year":"1994","journal-title":"Drugs Pharm. Sci."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/S0169-409X(02)00116-3","article-title":"Influence of microemulsions on cutaneous drug delivery","volume":"54","author":"Kreilgaard","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_144","unstructured":"Gasco, M.R. (1993). Method for Producing Solid Lipid Microspheres Having a Narrow Size Distribution. (US5250236), US Patent."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0939-6411(97)00107-0","article-title":"NMR relaxometric investigations of solid lipid nanoparticles (SLN) containing gadolinium (III) complexes","volume":"45","author":"Morel","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1061186031000086108","article-title":"In vitro and in vivo study of solid lipid nanoparticles loaded with superparamagnetic iron oxide","volume":"11","author":"Peira","year":"2003","journal-title":"J. Drug Target."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/jps.21434","article-title":"Production of solid lipid submicron particles for protein delivery using a novel supercritical gas-assisted melting atomization process","volume":"98","author":"Salmaso","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.supflu.2010.05.013","article-title":"Production of lipid microparticles containing bioactive molecules functionalized with PEG","volume":"54","author":"Borin","year":"2010","journal-title":"J. Supercrit. Fluids"},{"key":"ref_149","unstructured":"Bertucco, A., Caliceti, P., and Elvassore, N. (2007). Process for the Production of Nanoparticles. (WO2007028421), WIPO Patent."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0021-9797(69)80012-3","article-title":"The stability of O\/W type emulsions as functions of temperature and the HLB of emulsifiers: The emulsification by PIT-method","volume":"30","author":"Shinoda","year":"1969","journal-title":"J. Colloid Interface Sci."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpharm.2009.04.026","article-title":"Lipid nanocapsules: A new platform for nanomedicine","volume":"379","author":"Huynh","year":"2009","journal-title":"Int. J. Pharm."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3109\/03639045.2010.539231","article-title":"In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain","volume":"37","author":"Montenegro","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2174\/187221111797200588","article-title":"Powdered lipid nano and microparticles: Production and applications","volume":"5","author":"Berton","year":"2011","journal-title":"Recent Pat. Drug Deliv. Formul."},{"key":"ref_154","first-page":"104","article-title":"Investigations on solid lipid nanoparticles prepared by precipitation in o\/w emulsions","volume":"42","author":"Siekmann","year":"1996","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0378-5173(03)00135-2","article-title":"Preparation of solid lipid nanoparticles by a solvent emulsification\u2013diffusion technique","volume":"257","author":"Trotta","year":"2003","journal-title":"Int. J. Pharm."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0927-7765(02)00053-X","article-title":"Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules","volume":"27","author":"Torres","year":"2003","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1080\/02652040802390156","article-title":"Preparation of solid lipid nanoparticles from W\/O\/W emulsions: Preliminary studies on insulin encapsulation","volume":"26","author":"Gallarate","year":"2009","journal-title":"J. Microencapsul."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0939-6411(02)00130-3","article-title":"Solvent injection as a new approach for manufacturing lipid nanoparticles\u2013evaluation of the method and process parameters","volume":"55","author":"Schubert","year":"2003","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0378-5173(02)00081-9","article-title":"Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization","volume":"239","author":"Hu","year":"2002","journal-title":"Int. J. Pharm."},{"key":"ref_160","unstructured":"Rodriguez, L., Cini, M., Cavallari, C., and Motta, G. (1998). Apparatus and Method for Preparing Solid Forms with Controlled Release of the Active Ingredient. (AU693539B2), Australian Patent."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/jps.21854","article-title":"Solid lipid microparticles produced by spray congealing: Influence of the atomizer on microparticle characteristics and mathematical modeling of the drug release","volume":"99","author":"Passerini","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"ref_162","unstructured":"Swarbrick, J., and Boylan, J.C. (2000). Spray drying and spray congealing of pharmaceuticals. Encyclopedia of Pharmaceutical Technology, Informa Healthcare, Inc."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2010.03.017","article-title":"Formulation strategy and use of excipients in pulmonary drug delivery","volume":"392","author":"Pilcer","year":"2010","journal-title":"Int. J. Pharm."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejpb.2005.11.003","article-title":"Preparation and in vitro evaluation of lipidic carriers and fillers for inhalation","volume":"63","author":"Sebti","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_165","unstructured":"Chattopadhyay, P., Shekunov, B.Y., Seitzinger, J.S., and Huff, R.W. (2004). Particles from supercritical fluid extraction of emulsion. (WO2004004862A1), WIPO Patent."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.addr.2007.04.010","article-title":"Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system","volume":"59","author":"Chattopadhyay","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1081\/DIS-200045403","article-title":"Photostability and stability over time of retinyl palmitate in an O\/W emulsion and in SLN introduced in the emulsion","volume":"26","author":"Carlotti","year":"2005","journal-title":"J. Dispers. Sci. Technol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/S0142-9612(02)00578-1","article-title":"The production and characteristics of solid lipid nanoparticles (SLNs)","volume":"24","author":"Hou","year":"2003","journal-title":"Biomaterials"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/187221111797200597","article-title":"New methods for lipid nanoparticles preparation","volume":"5","author":"Corrias","year":"2011","journal-title":"Recent Pat. Drug Deliv. Formul."},{"key":"ref_170","unstructured":"Speiser, P. (1990). Lipidnanopellets als Tr\u00e4gersystem f\u00fcr Arzneimittel zur peroralen Anwendung. (167825), European Patent."},{"key":"ref_171","first-page":"259","article-title":"Optimization of procedure parameters and physical stability of solid lipid nanoparticles in dispersions","volume":"48","author":"Ahlin","year":"1998","journal-title":"Acta Pharm."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/1061186021000001832","article-title":"Lipid-drug-conjugate (LDC) nanoparticles as novel carrier system for the hydrophilic antitrypanosomal drug diminazenediaceturate","volume":"10","author":"Olbrich","year":"2002","journal-title":"J. Drug Target."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1015874121860","article-title":"Optimization of spray-dried and-congealed lipid micropellets and characterization of their surface morphology by scanning electron microscopy","volume":"8","author":"Eldem","year":"1991","journal-title":"Pharm. Res."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.2147\/IJN.S131893","article-title":"Development of solid lipid nanoparticles containing total flavonoid extract from Dracocephalum moldavica L. and their therapeutic effect against myocardial ischemia\u2013reperfusion injury in rats","volume":"12","author":"Tan","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1021\/bp990135c","article-title":"Gaulin homogenization: A mechanistic study","volume":"16","author":"Lander","year":"2000","journal-title":"Biotechnol. Prog."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"M\u00fcller, R.H., Benita, S., and Bohm, B. (1998). Emulsions and Nanosuspensions for the Formulation of Poorly Soluble Drugs, CRC Press.","DOI":"10.1016\/S0378-5173(97)00311-6"},{"key":"ref_177","unstructured":"zur Muhlen, A. (1996). Feste Lipid Nanopartikel mit Prolongierter Wirkstoffliberation: Herstellung, Langzeitstabilit\u00e4t, Charakterisierung, Freisetzungsverhalten und Mechanismen. [Ph.D. Thesis, Free University of Berlin]."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0378-5173(92)90051-3","article-title":"Preparation of submicron drug particles in lecithin-stabilized ow emulsions: I. Model studies of the precipitation of cholesteryl acetate","volume":"84","year":"1992","journal-title":"Int. J. Pharm."},{"key":"ref_179","first-page":"110","article-title":"Effects of some experimental factors on the production process of solid lipid nanoparticles","volume":"42","author":"Cavalli","year":"1996","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_180","first-page":"376","article-title":"Preparation of solid lipid nanoparticles loaded with Xionggui powder-supercritical carbon dioxide fluid extraction and their evaluation in vitro release","volume":"31","author":"Chen","year":"2006","journal-title":"Zhongguo Zhongyao Zazhi China J. Chin. Mater. Med."},{"key":"ref_181","first-page":"1","article-title":"Wettkampf und Spiel in den Miniaturen der Manessischen Liederhandschrift","volume":"14","author":"Meyer","year":"1988","journal-title":"Stadion"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0378-5173(02)00649-X","article-title":"Polymorphic properties of micronized carbamazepine produced by RESS","volume":"252","author":"Gosselin","year":"2003","journal-title":"Int. J. Pharm."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0939-6411(97)00172-0","article-title":"Spray-drying of solid lipid nanoparticles (SLNTM)","volume":"46","author":"Freitas","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Sguizzato, M., Esposito, E., Drechsler, M., Gallerani, E., Gavioli, R., Mariani, P., Carducci, F., Cortesi, R., and Bergamini, P. (2017). Nafion\u00ae-Containing Solid Lipid Nanoparticles as a Tool for Anticancer Pt Delivery: Preliminary Studies. J. Chem., 2017.","DOI":"10.1155\/2017\/3206298"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/S0142-9612(01)00362-3","article-title":"Production of lipospheres as carriers for bioactive compounds","volume":"23","author":"Cortesi","year":"2002","journal-title":"Biomaterials"},{"key":"ref_186","unstructured":"Heurtault, B., Saulnier, P., Benoit, J.-P., Proust, J.-E., Pech, B., and Richard, J. (2011). Lipid Nanocapsules, Preparation Process and Use as Medicine. (US8057823B2), US Patent."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"658","DOI":"10.7897\/2230-8407.0509134","article-title":"SLN brain targeting drug delivery for CNS: A novel approach","volume":"5","author":"Mori","year":"2014","journal-title":"Int. Res. J. Pharm"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1080\/17425247.2016.1201059","article-title":"Application of lipid nanoparticles to ocular drug delivery","volume":"13","author":"Battaglia","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s40199-018-0221-5","article-title":"Nicotinamide loaded functionalized solid lipid nanoparticles improves cognition in Alzheimer\u2019s disease animal model by reducing Tau hyperphosphorylation","volume":"26","author":"Vakilinezhad","year":"2018","journal-title":"DARU J. Pharm. Sci."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"111838","DOI":"10.1016\/j.colsurfb.2021.111838","article-title":"Systematically designed chitosan-coated solid lipid nanoparticles of ferulic acid for effective management of Alzheimer\u2019s disease: A preclinical evidence","volume":"205","author":"Saini","year":"2021","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"P199","DOI":"10.1016\/j.jalz.2012.05.544","article-title":"Neuroprotective potential of solid lipid nanoparticles of sesamol: Possible brain targeting strategy","volume":"8","author":"Misra","year":"2012","journal-title":"Alzheimers Dement."},{"key":"ref_192","first-page":"63","article-title":"Formulation and evaluation of galantamine nanoparticles for neurological disorders","volume":"5","author":"Nelluri","year":"2015","journal-title":"Int. J. Pharm. Chem. Biol. Sci."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.2042-7158.2010.01225.x","article-title":"Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery","volume":"63","author":"Dhawan","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3109\/1061186X.2012.747529","article-title":"Preparation, characterization, in vivo and biochemical evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimer\u2019s disease model","volume":"21","author":"Yusuf","year":"2013","journal-title":"J. Drug Target."},{"key":"ref_195","first-page":"1335","article-title":"Effect of nanoparticles binding \u03b2-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages","volume":"8","author":"Orlando","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1080\/10715760903214454","article-title":"Ferulic acid inhibits oxidative stress and cell death induced by Ab oligomers: Improved delivery by solid lipid nanoparticles","volume":"43","author":"Picone","year":"2009","journal-title":"Free Radic. Res."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ijpharm.2010.01.012","article-title":"Nanolipidic particles improve the bioavailability and \u03b1-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer\u2019s disease","volume":"389","author":"Smith","year":"2010","journal-title":"Int. J. Pharm."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1016\/j.fct.2011.08.006","article-title":"Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brain","volume":"49","author":"Kakkar","year":"2011","journal-title":"Food Chem. Toxicol."},{"key":"ref_199","first-page":"1171","article-title":"Preparation and entrapment efficiency determination of solid lipid nanoparticles loaded levodopa","volume":"14","author":"Zhan","year":"2010","journal-title":"Chin. J. Hosp. Pharm."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s11095-007-9514-y","article-title":"Solid lipid nanoparticles as delivery systems for bromocriptine","volume":"25","author":"Esposito","year":"2008","journal-title":"Pharm. Res."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/jps.22285","article-title":"Oral apomorphine delivery from solid lipid nanoparticles with different monostearate emulsifiers: Pharmacokinetic and behavioral evaluations","volume":"100","author":"Tsai","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/10717544.2012.752421","article-title":"Novel surface modified solid lipid nanoparticles as intranasal carriers for ropinirole hydrochloride: Application of factorial design approach","volume":"20","author":"Pardeshi","year":"2013","journal-title":"Drug Deliv."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s12017-013-8261-y","article-title":"Curcumin nanoparticles attenuate neurochemical and neurobehavioral deficits in experimental model of Huntington\u2019s disease","volume":"16","author":"Sandhir","year":"2014","journal-title":"Neuromolecular Med."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3109\/10717544.2014.880860","article-title":"Development, characterization and nasal delivery of rosmarinic acid-loaded solid lipid nanoparticles for the effective management of Huntington\u2019s disease","volume":"22","author":"Bhatt","year":"2015","journal-title":"Drug Deliv."},{"key":"ref_205","first-page":"1","article-title":"Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach","volume":"116","author":"Fievez","year":"2006","journal-title":"J. Control. Release"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1158\/1535-7163.MCT-06-0289","article-title":"A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats","volume":"5","author":"Garcion","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.addr.2007.04.011","article-title":"Solid lipid nanoparticles for targeted brain drug delivery","volume":"59","author":"Blasi","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.addr.2011.10.007","article-title":"Nanotechnological advances for the delivery of CNS therapeutics","volume":"64","author":"Wong","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/10717544.2011.644349","article-title":"Carbamazepine mucoadhesive nanoemulgel (MNEG) as brain targeting delivery system via the olfactory mucosa","volume":"19","author":"Samia","year":"2012","journal-title":"Drug Deliv."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1208\/s12249-009-9197-2","article-title":"Diazepam-loaded solid lipid nanoparticles: Design and characterization","volume":"10","author":"Abdelbary","year":"2009","journal-title":"Aaps Pharmscitech."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1002\/jps.24044","article-title":"Nanoparticle formulation improves the anticonvulsant effect of clonazepam on the pentylenetetrazole-induced seizures: Behavior and electroencephalogram","volume":"103","author":"Couraud","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1166\/jnn.2014.8722","article-title":"Formulation and optimization of raloxifene-loaded solid lipid nanoparticles to enhance oral bioavailability","volume":"14","author":"Tran","year":"2014","journal-title":"J. Nanosci. Nanotechnol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1208\/s12248-015-9811-z","article-title":"Therapeutic applications of curcumin nanoformulations","volume":"17","author":"Yallapu","year":"2015","journal-title":"AAPS J."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1016\/j.biomaterials.2008.07.008","article-title":"The role of daidzein-loaded sterically stabilized solid lipid nanoparticles in therapy for cardio-cerebrovascular diseases","volume":"29","author":"Gao","year":"2008","journal-title":"Biomaterials"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3109\/10837450.2012.734513","article-title":"Brain targeted solid lipid nanoparticles for brain ischemia: Preparation and in vitro characterization","volume":"18","author":"Morsi","year":"2013","journal-title":"Pharm. Dev. Technol."},{"key":"ref_216","unstructured":"Frautschy, S.A., and Cole, G.M. (2015). Bioavailable Curcuminoid Formulations for Treating Alzheimer\u2019s Disease and Other Age-Related Disorders. (US20090324703A1), US Patent."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11051-014-2347-9","article-title":"Luteolin-loaded solid lipid nanoparticles synthesis, characterization, & improvement of bioavailability, pharmacokinetics in vitro and vivo studies","volume":"16","author":"Dang","year":"2014","journal-title":"J. Nanoparticle Res."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11019-014-9559-8","article-title":"Alzheimer, dementia and the living will: A proposal","volume":"17","author":"Rego","year":"2014","journal-title":"Med. Health Care Philos."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1093\/brain\/awh177","article-title":"Cholinergic enhancement of frontal lobe activity in mild cognitive impairment","volume":"127","author":"Saykin","year":"2004","journal-title":"Brain"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1756285612461679","article-title":"Current and future treatments for Alzheimer\u2019s disease","volume":"6","author":"Yiannopoulou","year":"2013","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/cmdc.201200320","article-title":"(R)-\u03b1-Lipoyl-Glycyl-l-Prolyl-l-Glutamyl Dimethyl Ester Codrug as a Multifunctional Agent with Potential Neuroprotective Activities","volume":"7","author":"Cacciatore","year":"2012","journal-title":"ChemMedChem"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ardp.200900152","article-title":"Ibuprofen and lipoic acid diamides as potential codrugs with neuroprotective activity","volume":"343","author":"Sozio","year":"2010","journal-title":"Arch. Der Pharm. Int. J. Pharm. Med. Chem."},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"Topal, G.R., M\u00e9sz\u00e1ros, M., Porkol\u00e1b, G., Szecsk\u00f3, A., Polg\u00e1r, T.F., Sikl\u00f3s, L., Deli, M.A., Veszelka, S., and Bozkir, A. (2021). ApoE-Targeting Increases the Transfer of Solid Lipid Nanoparticles with Donepezil Cargo across a Culture Model of the Blood\u2013Brain Barrier. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13010038"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1166\/jbn.2015.1925","article-title":"Intracellular uptake of curcumin-loaded solid lipid nanoparticles exhibit anti-inflammatory activities superior to those of curcumin through the NF-\u03baB signaling pathway","volume":"11","author":"Wang","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.biomaterials.2015.02.116","article-title":"Anti-inflammatory activity of curcumin-loaded solid lipid nanoparticles in IL-1\u03b2 transgenic mice subjected to the lipopolysaccharide-induced sepsis","volume":"53","author":"Wang","year":"2015","journal-title":"Biomaterials"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/17458080.2015.1025301","article-title":"Ceramide\u2013palmitic acid complex based Curcumin solid lipid nanoparticles for transdermal delivery: Pharmacokinetic and pharmacodynamic study","volume":"11","author":"Gaur","year":"2016","journal-title":"J. Exp. Nanosci."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1017\/S0317167100041457","article-title":"Frequency and cause of Parkinson\u2019s disease","volume":"19","author":"Rajput","year":"1992","journal-title":"Can. J. Neurol. Sci."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1080\/17425247.2016.1178237","article-title":"Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases","volume":"13","author":"Cacciatore","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/ardp.200700228","article-title":"New L-dopa codrugs as potential antiparkinson agents","volume":"341","author":"Sozio","year":"2008","journal-title":"Arch. Der Pharm. Int. J. Pharm. Med. Chem."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s00726-011-1210-x","article-title":"Molecular mechanism underlying the cerebral effect of Gly-Pro-Glu tripeptide bound to L-dopa in a Parkinson\u2019s animal model","volume":"43","author":"Minelli","year":"2012","journal-title":"Amino Acids"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.freeradbiomed.2010.03.011","article-title":"N-Acetyl-L-Methionyl-L-Dopa-Methyl Ester as a dual acting drug that relieves L-Dopa-induced oxidative toxicity","volume":"49","author":"Minelli","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2165\/00023210-200721080-00005","article-title":"Medical management of levodopa-associated motor complications in patients with Parkinson\u2019s disease","volume":"21","author":"Jankovic","year":"2007","journal-title":"CNS Drugs"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0960-894X(00)00249-3","article-title":"Synthesis of L-(+)-3-(3-hydroxy-4-pivaloyloxybenzyl)-2, 5-diketomorpholine as potential prodrug of L-dopa","volume":"10","author":"Cingolani","year":"2000","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"64","DOI":"10.31157\/archneurosciencesmex.v21i1.112","article-title":"Mexican consensus on the diagnosis of Huntington\u2019s disease","volume":"21","author":"Carrasco","year":"2016","journal-title":"Arch. Neurocienc."},{"key":"ref_235","unstructured":"National Institute of Neurological Disorders and Stroke (1994). Parkinson\u2019s Disease: Hope through Research."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/ene.14294","article-title":"How have advances in genetic technology modified movement disorder nosology?","volume":"27","author":"Sturchio","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1161\/01.STR.0000237236.88823.47","article-title":"National Institute of Neurological Disorders and Stroke\u2013Canadian stroke network vascular cognitive impairment harmonization standards","volume":"37","author":"Hachinski","year":"2006","journal-title":"Stroke"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S0140-6736(08)61619-0","article-title":"Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: A multicentre, randomised, double-blind, placebo-controlled phase IIb study","volume":"372","author":"Kappos","year":"2008","journal-title":"Lancet"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/1352458509359725","article-title":"Neurofilament light as a prognostic marker in multiple sclerosis","volume":"16","author":"Salzer","year":"2010","journal-title":"Mult. Scler. J."},{"key":"ref_240","first-page":"336","article-title":"The effect of a pain management program in reducing the pain in patients with multiple sclerosis","volume":"6","author":"Michaeli","year":"2016","journal-title":"J. Res. Health"},{"key":"ref_241","first-page":"25","article-title":"Surface engineering of macrophages with nanoparticles to generate a cell\u2013nanoparticle hybrid vehicle for hypoxia-targeted drug delivery","volume":"5","author":"Holden","year":"2010","journal-title":"Int. J. Nanomed."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1227\/01.neu.0000318159.21731.cf","article-title":"Glioma extent of resection and its impact on patient outcome","volume":"62","author":"Sanai","year":"2008","journal-title":"Neurosurgery"},{"key":"ref_243","unstructured":"\u00d6zdemir, Y.G., Pehlivan, S.B., and Sekerdag, E. (2017). Nanotechnology Methods for Neurological Diseases and Brain Tumors: Drug Delivery Across the Blood\u2013Brain Barrier, Academic Press."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.nurt.2009.04.004","article-title":"Novel drug delivery strategies in neuro-oncology","volume":"6","author":"Bidros","year":"2009","journal-title":"Neurotherapeutics"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1016\/j.biomaterials.2011.04.060","article-title":"The promotion of microvasculature formation in poly (ethylene glycol) diacrylate hydrogels by an immobilized VEGF-mimetic peptide","volume":"32","author":"Saik","year":"2011","journal-title":"Biomaterials"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.colsurfb.2011.02.011","article-title":"Catanionic solid lipid nanoparticles carrying doxorubicin for inhibiting the growth of U87MG cells","volume":"85","author":"Kuo","year":"2011","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jconrel.2019.11.016","article-title":"A glance over doxorubicin based-nanotherapeutics: From proof-of-concept studies to solutions in the market","volume":"317","author":"Mignani","year":"2020","journal-title":"J. Control. Release"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/jps.24388","article-title":"Inhibition against growth of glioblastoma multiforme in vitro using etoposide-loaded solid lipid nanoparticles with \u03c1-Aminophenyl-\u03b1-D-manno-pyranoside and folic acid","volume":"104","author":"Kuo","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3109\/1061186X.2015.1132223","article-title":"Enhanced delivery of etoposide across the blood\u2013brain barrier to restrain brain tumor growth using melanotransferrin antibody-and tamoxifen-conjugated solid lipid nanoparticles","volume":"24","author":"Kuo","year":"2016","journal-title":"J. Drug Target."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jconrel.2011.07.030","article-title":"In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma","volume":"156","author":"Mollinedo","year":"2011","journal-title":"J. Control. Release"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijpharm.2012.03.032","article-title":"Solid lipid nanoparticles as intracellular drug transporters: An investigation of the uptake mechanism and pathway","volume":"430","author":"Martins","year":"2012","journal-title":"Int. J. Pharm."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijpharm.2014.08.003","article-title":"In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery","volume":"474","author":"Jose","year":"2014","journal-title":"Int. J. Pharm."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.ejpb.2014.10.017","article-title":"Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment","volume":"88","author":"Chirio","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"336","DOI":"10.2174\/1389200215666141125142605","article-title":"A synopsis of nano-technological approaches toward anti-epilepsy therapy: Present and future research implications","volume":"16","author":"Jabir","year":"2015","journal-title":"Curr. Drug Metab."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.nurt.2009.01.018","article-title":"Nanotechnology for delivery of drugs to the brain for epilepsy","volume":"6","author":"Bennewitz","year":"2009","journal-title":"Neurotherapeutics"},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1046\/j.1528-1157.2002.11202.x","article-title":"Effectiveness of muscimol-containing microparticles against pilocarpine-induced focal seizures","volume":"43","author":"Kohane","year":"2002","journal-title":"Epilepsia"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.euroneuro.2006.05.003","article-title":"Comparative efficacy of liposome-entrapped amiloride and free amiloride in animal models of seizures and serum potassium in mice","volume":"17","author":"Ali","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-7-97","article-title":"Inflammatory mechanisms in ischemic stroke: Therapeutic approaches","volume":"7","author":"Lakhan","year":"2009","journal-title":"J. Transl. Med."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1161\/STR.0b013e318296aeca","article-title":"An updated definition of stroke for the 21st century: A statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"44","author":"Sacco","year":"2013","journal-title":"Stroke"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev.ne.13.030190.001131","article-title":"The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death","volume":"13","author":"Choi","year":"1990","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1023\/A:1025682611389","article-title":"Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: Implications for the pathogenesis of neurodegenerative diseases","volume":"28","author":"Rego","year":"2003","journal-title":"Neurochem. Res."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/bs.apha.2014.06.013","article-title":"Drug delivery to the ischemic brain","volume":"71","author":"Thompson","year":"2014","journal-title":"Adv. Pharmacol."},{"key":"ref_263","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Nieto, D., Fern\u00e1ndez-Serra, R., P\u00e9rez-Rigueiro, J., Panetsos, F., Martinez-Murillo, R., and Guinea, G.V. (2020). Biomaterials to neuroprotect the stroke brain: A large opportunity for narrow time windows. Cells, 9.","DOI":"10.3390\/cells9051074"},{"key":"ref_264","doi-asserted-by":"crossref","unstructured":"Sarmah, D., Saraf, J., Kaur, H., Pravalika, K., Tekade, R.K., Borah, A., Kalia, K., Dave, K.R., and Bhattacharya, P. (2017). Stroke management: An emerging role of nanotechnology. Micromachines, 8.","DOI":"10.3390\/mi8090262"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ijpharm.2010.12.045","article-title":"Macrophages and liposomes in inflammatory disease: Friends or foes?","volume":"416","author":"Crielaard","year":"2011","journal-title":"Int. J. Pharm."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejpb.2013.02.005","article-title":"Curcumin loaded solid lipid nanoparticles: An efficient formulation approach for cerebral ischemic reperfusion injury in rats","volume":"85","author":"Kakkar","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ijpharm.2011.12.009","article-title":"Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting","volume":"423","author":"Tsai","year":"2012","journal-title":"Int. J. Pharm."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-016-0177-x","article-title":"Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E","volume":"14","author":"Neves","year":"2016","journal-title":"J. Nanobiotechnology"},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.lfs.2017.11.046","article-title":"Ferulic acid-loaded nanostructured lipid carriers: A promising nanoformulation against the ischemic neural injuries","volume":"193","author":"Hassanzadeh","year":"2018","journal-title":"Life Sci."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1517\/13543784.11.10.1407","article-title":"Antioxidants as treatment for neurodegenerative disorders","volume":"11","author":"Moosmann","year":"2002","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0014-827X(03)00135-6","article-title":"Synthesis and activity of novel glutathione analogues containing an urethane backbone linkage","volume":"58","author":"Cacciatore","year":"2003","journal-title":"Il Farm."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/02652040500162378","article-title":"A novel approach based on lipid nanoparticles (SLN\u00ae) for topical delivery of \u03b1-lipoic acid","volume":"22","author":"Souto","year":"2005","journal-title":"J. Microencapsul."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijpharm.2015.03.001","article-title":"Solid lipid nanoparticles loaded with lipoyl\u2013memantine codrug: Preparation and characterization","volume":"485","author":"Laserra","year":"2015","journal-title":"Int. J. Pharm."},{"key":"ref_274","unstructured":"Duarte, A.M.G. (2015). Resveratrol and Grape\u2019s Extract-Loaded Solid Lipid Nanoparticles for the Treatment of Parkinson\u2019s and Alzheimer\u2019s Diseases. [Master\u2019s Thesis, Faculty of Engineering of University of Porto]."},{"key":"ref_275","doi-asserted-by":"crossref","unstructured":"Loureiro, J.A., Andrade, S., Duarte, A., Neves, A.R., Queiroz, J.F., Nunes, C., Sevin, E., Fenart, L., Gosselet, F., and Coelho, M.A.N. (2017). Resveratrol and Grape Extract-loaded Solid Lipid Nanoparticles for the Treatment of Alzheimer\u2019s Disease. Molecules, 22.","DOI":"10.3390\/molecules22020277"},{"key":"ref_276","doi-asserted-by":"crossref","unstructured":"Fernandes, F., Dias-Teixeira, M., Delerue-Matos, C., and Grosso, C. (2021). Critical Review of Lipid-Based Nanoparticles as Carriers of Neuroprotective Drugs and Extracts. Nanomaterials, 11.","DOI":"10.3390\/nano11030563"},{"key":"ref_277","doi-asserted-by":"crossref","unstructured":"Thi, T.T.H., Suys, E.J., Lee, J.S., Nguyen, D.H., Park, K.D., and Truong, N.P. (2021). Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines. Vaccines, 9.","DOI":"10.3390\/vaccines9040359"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/cen.13993","article-title":"Different routes and formulations of melatonin in critically ill patients. A pharmacokinetic randomized study","volume":"91","author":"Mistraletti","year":"2019","journal-title":"Clin. Endocrinol."}],"updated-by":[{"DOI":"10.3390\/pharmaceutics18091078","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000}}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/13\/8\/1183\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:07:19Z","timestamp":1787850439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/13\/8\/1183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,31]]},"references-count":278,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["pharmaceutics13081183"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics13081183","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,31]]}}}